-- 周三,欧洲天然气期货价格上涨超过2%,此前伊朗在霍尔木兹海峡扣押了两艘船只,标志着冲突显著升级。 荷兰TTF近月期货价格上涨1.12%,至每兆瓦时42.40欧元(49.74美元);英国NBP期货价格上涨0.87%,至每热量单位106.03便士(1.43美元)。 据伊朗塔斯尼姆通讯社报道,伊朗伊斯兰革命卫队周三表示,他们在具有重要战略意义的霍尔木兹海峡拦截并扣押了两艘违反规定的船只。 伊朗伊斯兰革命卫队海军称,这两艘名为“MSC-Francesca”号和“Epaminodes”号的船只在未获得适当授权的情况下在海峡作业,并操纵导航辅助系统,危及该地区的海上安全。 这些船只已被转移至伊朗领海,以便对其货物、文件和其他记录进行彻底检查。 就在几个小时前,美国总统唐纳德·特朗普在Truth Social上发帖称,他将延长与伊朗为期两周的停火协议,给予伊朗时间提交其方案并完成谈判,尽管伊朗仍处于美国的海上封锁之下。 与此同时,伊朗表示并未要求停火。据塔斯尼姆通讯社报道,伊朗常驻联合国代表赛义德·伊拉瓦尼表示,如果美国解除对伊朗的封锁,德黑兰愿意进行谈判。 “我们已经收到一些迹象,表明美国准备打破(海上封锁),一旦他们这样做,我认为下一轮谈判将在伊斯兰堡举行,”他说。 据霍尔木兹海峡监测机构称,霍尔木兹海峡已连续第八周处于事实上的封闭状态,过去24小时内仅有5艘船只通过。 尽管近几日海峡的交通流量有所回升,但在如此多的干扰和不确定性下,这种回升势头能否持续仍有待观察。 与此同时,据欧洲天然气基础设施协会(Gas Infrastructure Europe)的数据显示,欧洲天然气库存仍然处于低位,仅为产能的30.61%,而去年同期为37.04%。
Related Articles
Scotiabank Previews This Week's February and Preliminary March GDP for Canada
Canada reports gross domestic product for February and the preliminary estimate for March on Thursday, said Scotiabank.February was initially guided by Statistics Canada to have been tracking a 0.2% month-over-month gain last month. Updated estimates are still in the same ballpark, but investors also get important details on sector drivers, noted the bank.More meaningful may be the flash guidance, with no details, for March GDP, for which there is very little information so far, but a small gain is "feasible," stated Scotiabank.The outcome will further inform Q1 GDP growth tracking on a production/income basis using monthly GDP. It's feasible that growth is tracking close to the Bank of Canada's 1.8% January Monetary Policy Report estimate, but that's on an expenditure basis. The massive over 4% inventory drag on Q4 GDP could reverse as an added upside, pointed out the bank.One key is that consumer spending on goods is tracking a strong rebound in Q1 based on retail sales volumes. It's untrue that the economy isn't exhibiting rate sensitivity, a view that is disproportionately driven by a false understanding of what's keeping condo markets weak in Toronto and Vancouver, added Scotiabank.
Vicor Insider Sold Shares Worth $2,079,226, According to a Recent SEC Filing
Alvaro Doyle, Vice President and Chief Information Officer, on April 23, 2026, sold 8,000 shares in Vicor (VICR) for $2,079,226. Following the Form 4 filing with the SEC, Doyle has control over a total of 42 common shares of the company, with 42 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/751978/000182673026000002/xslF345X05/primary_doc.xmlPrice: $265.29, Change: $-8.24, Percent Change: -3.01%
BioMarin Seen Building Broader Rare-Disease Platform After Amicus Deal, Morgan Stanley Says
BioMarin Pharmaceutical (BMRN) is emerging as a broader rare-disease platform as its acquisition of Amicus Therapeutics (FOLD) adds two approved medicines and reduces reliance on Voxzogo, Morgan Stanley said Monday in a report.The Amicus deal reshapes BioMarin's outlook by adding Galafold and Pombiliti with Opfolda, products that fit the company's global commercial network, the report said. The therapies are expected to generate more than $1.3 billion in revenue by 2030, Morgan Stanley said.The acquisition is projected to accelerate revenue growth immediately after closing and to be accretive to non-GAAP earnings within 12 months, with "substantial accretion" beginning in 2027, the report said. BioMarin closed its $4.8 billion purchase of Amicus on Monday.Morgan Stanley resumed coverage on BioMarin stock with an overweight rating and a $120 price target.Price: $54.08, Change: $+0.90, Percent Change: +1.68%